The Pharmacovigilance Department’s objective is to ensure the health of the general public; it monitors, records, evaluates and reports the side-effects of pharmaceuticals already released to the market as well as those tested in clinical trials before their approval, as dictated by European legislation, both to the National Organization for Medicines and to the European Organization for Medicines
GENEPHARM S.A.18km Marathon Avenue 15351 Pallini, Greece Tel: +30 210 603 9336 Fax: +30 210 603 9402 Email:This email address is being protected from spambots. You need JavaScript enabled to view it.